All In Biotech

Free tool

FAERS Monitor: Feraheme

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022180 or its brand name (Feraheme, Ferumoxytol). Reports on generic versions are filed under their own applications.

Reports

1,942

Serious

1,190

61% of reports

Hospitalization

463

Death reported

131

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea468
  • nausea242
  • flushing230
  • back pain211
  • infusion related reaction211
  • hypotension205
  • anaphylactic reaction185
  • dizziness183
  • chest discomfort175
  • hypersensitivity155
  • chest pain139
  • unresponsive to stimuli139
  • vomiting137
  • hyperhidrosis110
  • pruritus100

Reports by year received

View as table
YearReports
200915
2010199
201196
201275
201345
201465
201575
2016101
2017119
2018150
2019246
2020176
2021154
2022103
202385
202486
202580
202672

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,217 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
unresponsive to stimuliSignal13958.649.97,785
anaphylactic reactionSignal18536.431.76,326
infusion related reactionSignal21134.630.46,847
flushingSignal23024.621.75,187
chest discomfortSignal17518.516.12,895
hypotensionSignal20511.19.71,886
back painSignal2119.88.71,685
hyperhidrosisSignal1109.37.7806
hypersensitivitySignal1559.17.81,111
dyspnoeaSignal4689.08.33,390
chest painSignal1398.16.9870
dizzinessSignal1834.03.5414
nauseaSignal2423.32.9403
vomitingSignal1373.22.7204
pruritusSignal1002.82.3118

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.